The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Cell Therapy Packaging Products and Services Market by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging), Scale of Operation (Clinical and Commercial) and Geography (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030

  • Lowest Price Guaranteed From USD 5,899

  • Published
    June 2021

  • Pages
    180

  • View Count
    345

Example Insights

Cell-Therapy-Packaging-Products-and-Services-Market-Context 	Cell-Therapy-Packaging-Products-and-Services-Market-Service-Providers Cell-Therapy-Packaging-Products-and-Services-Market-Distribution
Cell-Therapy-Packaging-Products-and-Services-Market-Packaging-Of-Cell-Therapy-Products 	Cell-Therapy-Packaging-Products-and-Services-Market-Company-Competitiveness-Analysis 	Cell-Therapy-Packaging-Products-and-Services-Market-Partnerships-and-Collaborations
Cell-Therapy-Packaging-Products-and-Services-Market-Partners-for-Packaging-Providers Cell-Therapy-Packaging-Products-and-Services-Market-Manufacturers Cell-Therapy-Packaging-Products-and-Services-Market-Future-Opportunity

 

Overview

Given their ability to treat a wide range of clinical conditions, advanced therapy medicinal products, including cell and gene therapies, have revolutionized the delivery of healthcare. Presently, more than 30 cell-based therapy products have received marketing approvals across various geographies, while more than 1,000 therapeutic candidates are under clinical evaluation. Considering the lucrative investment opportunity within this domain, several investors are actively supporting ongoing / future product development programs in this upcoming field of pharmacological interventions. In fact, there has been a 240% increase in investment activity,  in terms of capital amount invested, between 2019 and 2020. However, the ultimate success of cell therapies is dependent on the safe and timely delivery of viable doses of therapeutic cells to the right patient. In this context, it is worth highlighting that drug product manufacturing, packaging and logistics operations involving cell therapies are both complex and challenging. Moreover, in order to ensure the stability of such products across the supply chain, specific temperature conditions (cryogenic, ambient or refrigerated) are required, in addition to specialized packaging material. Considering that most cell therapies are personalized, it is imperative that errors in labeling are avoided at all costs. 

Given the need for costly and specialized equipment and the complexities associated with handling cell-based therapy products, innovators in the healthcare industry are likely to involve contract service providers for their drug product production, packaging and transportation requirements. Over time, regulators across the world, including the US Food and Drug Administration (FDA) and the International Air Transport Association (IATA), have established guidelines for the packaging, storage and transport of cell therapies. Since CMOs / CDMOs with the necessary capabilities to handle cell therapies are also likely to have established processes that comply with the current acceptable standards across different global regions, it is better for therapy developers to strategically partner with the aforementioned players instead of focusing on developing in-house capabilities. Presently, close to 60 companies claim to be offering cell therapy packaging services and associated products.  In fact, it is estimated that close to 30% of drug substance and drug product related operations of advanced therapy medicinal products are already outsourced to capable CMOs / CDMOs. Further, over the last few years, several service providers have also forged strategic alliances among themselves, in order to further expand existing capabilities and augment their respective service offerings. Given the rising trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios, we believe that the cell therapy packaging products and services market is likely to evolve at a steady pace in the next few years.

Scope of the Report

The “Cell Therapy Packaging Products and Services Market by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging), Scale of Operation (Clinical and Commercial) and Geography (North America, Europe, Asia Pacific and Rest of the World) , 2021-2030” report features an elaborate study of the current scenario and future opportunity within the cell therapy packaging products and services market. In addition, the report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain.  Amongst other elements, the report includes:

  • An overview of the current market landscape of cell therapy packaging services providers, including a detailed analysis based on their year of establishment, company size, location of headquarters, package engineering design (primary and secondary), type of packaging (active and passive), packaging material (dry ice and liquid nitrogen),  type of passive system used, temperature ranges supported, type of cells handled and additional services offered. 
  • A detailed assessment of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bags, vials, shipping container and others), container fabrication material (plastic and others), storage temperature conditions, type of cells packed and usability of containers. In addition, the chapter highlights analysis of cell therapy packaging product provider(s), based on various parameters such as year of establishment, company size and location of headquarters and key players.
  • An in-depth competitiveness analysis of cell therapy packaging service providers based in different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported) service portfolio (type of additional services offered) and company size (small, mid-sized and large companies).
  • An analysis of the various partnerships established between cell therapy packaging providers and cell therapy developers, during the period, 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders engaged in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service covered and geographical location of players involved in a partnership.
  • A list of more than 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).
  • A case study highlighting the companies that claim to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.
  • Detailed profiles of the key players offering cell therapy packaging services and products. Each profile includes a brief overview of the company, details on cell therapy service portfolio, information on cell therapy packaging product portfolio, recent developments and an informed future outlook.

One of the key objectives of the report was to estimate the existing market size and future growth potential of the cell therapy packaging providers market. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. Our year-wise projections of the current and future opportunity have further been segmented across [A] type of therapy (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK cell therapies and other advanced therapy medicinal products), [B] package engineering design (primary and secondary packaging), [C] scale of operation (clinical and commercial) and [D] geography (North America, Europe, Asia Pacific and Rest of the World)

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the leading players offering cell therapy packaging services and products?
  • What are the key considerations and challenges associated with cell therapy packaging?
  • Which partnership models are commonly adopted by stakeholders engaged in this industry?
  • Which players are likely to partner with cell therapy packaging service and product providers?
  • What factors are likely to influence the evolution of the cell therapy packaging service providers market?
  • What are the likely future trends in cell therapy packaging services market?
  • How is the current and future opportunity likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of cell therapy packaging providers market and its likely evolution in the short-mid to long term.

Chapter 3 provides a general introduction to the pharmaceutical filling and packaging, including information on types of pharmaceutical packaging. The chapter lays emphasis on cell therapy packaging, primary and secondary packaging of cell therapies. In addition, it discusses the key considerations and challenges associated with cell therapy packaging.

Chapter 4 features an overview of the current market landscape of cell therapy packaging services providers, including a detailed analysis on the year of establishment, company size and location of headquarters. In addition, the chapter highlights the analysis on the package engineering design (primary and secondary), type of packaging (active and passive), packaging material (dry ice and liquid nitrogen) and type of passive system used. Further, the chapter also presents analysis on temperature ranges supported, type of cells handled and additional services offered.

Chapter 5 presents a detailed assessment of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bags, vials, shipping container and others), container fabrication material (plastic and others), storage temperature conditions, type of cells packed and usability of containers. In addition, the chapter highlights analysis of cell therapy packaging product provider(s), based on various parameters such as year of establishment, company size and location of headquarters and key players.

Chapter 6 includes profiles of the key players offering cell therapy packaging services and products. Each profile includes a brief overview of the company, details on cell therapy service portfolio, information on cell therapy packaging product portfolio, recent developments and an informed future outlook.

Chapter 7 presents in-depth competitiveness analysis of cell therapy packaging service providers based in different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported) service portfolio (type of additional services offered) and company size (small, mid-sized and large companies).

Chapter 8 provides an analysis of the various partnerships established  between cell therapy packaging providers and cell therapy developers, during the period, 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders engaged in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service covered and geographical location of players involved in a partnership.

Chapter 9 presents a list of more than 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).

Chapter 10 features a case study highlighting the companies that claim to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter  presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.

Chapter 11 presents a detailed market forecast analysis, providing insights on the likely growth of continuous manufacturing equipment providers market for the period 2021-2030. In addition, the chapter presents the likely distribution of the projected future opportunity based on type of therapy (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK cell therapies and other advanced therapy medicinal products), package engineering design (primary and secondary packaging), scale of operation (clinical and commercial) and geography (North America, Europe, Asia Pacific and Rest of the World).

Chapter 12  is a summary of the overall report, which presents the insights on the contemporary market trends and the likely evolution of cell therapy products and services market. 

Chapter 13 is an appendix that contains tabulated data and numbers for all the figures provided in the report.

Chapter 14 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview 
3.2. Pharmaceutical Filling and Packaging
3.3. Importance of Pharmaceutical Packaging
3.4. Types of Pharmaceutical Packaging
3.5. Packaging of Cell Therapies
3.5.1. Primary Packaging 
3.5.2. Secondary Packaging

3.6. Cell Therapy Packaging: Key Considerations
3.7. Challenges associated with Cell Therapy Packaging
3.8. Concluding Remarks

4. CELL THERAPY PACKAGING SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Cell Therapy Packaging Service Providers Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Package Engineering Design
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Type of Packaging Material
4.2.7. Analysis by Type of Passive System Used
4.2.8. Analysis by Temperature Ranges Supported
4.2.9. Analysis by Type of Cells Handled
4.2.10. Analysis by Type of Additional Service(s) Offered
4.2.11. Logo Landscape: Key Players offering Additional Services

5. CELL THERAPY PACKAGING PRODUCT PROVIDERS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Cell Therapy Packaging Products: Market Landscape
5.2.1. Analysis by Type of Packaging Container
5.2.2. Analysis by Container Fabrication Material
5.2.3. Analysis by Type of Packaging Container and Container Fabrication Material
5.2.4. Analysis by Storage Temperature Conditions
5.2.5. Analysis by Type of Packaging Container and Storage Temperature Conditions
5.2.6. Analysis by Type of Cells Packed
5.2.7. Analysis by Usability of Container

5.3. Cell Therapy Packaging Product Providers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters

6. CELL THERAPY PACKAGING SERVICE AND PRODUCT PROVIDERS: COMPANY PROFILES
6.1. Chapter Overview
6.2 Cell Therapy Packaging Service Providers
6.2.1. Almac
6.2.1.1. Company Overview
6.2.1.2. Cell Therapy Service Portfolio
6.2.1.3. Recent Developments and Future Outlook

6.2.2. Catalent Pharma Solutions
6.2.2.1. Company Overview
6.2.2.2. Cell Therapy Service Portfolio
6.2.2.3. Recent Developments and Future Outlook
6.2.3. Cryoport Systems
6.2.3.1. Company Overview
6.2.3.2. Cell Therapy Service Portfolio
6.2.3.3. Recent Developments Future Outlook

6.2.4. Yourway
6.2.4.1. Company Overview
6.2.4.2. Cell Therapy Service Portfolio
6.2.4.3. Recent Developments and Future Outlook

6.3. Cell Therapy Packaging Product Providers
6.3.1. Lufthansa Cargo
6.3.1.1. Company Overview
6.3.1.2. Cell Therapy Packaging Product Portfolio
6.3.1.3. Recent Developments and Future Outlook

6.3.2. Saint-Gobain Life Sciences
6.3.2.1. Company Overview
6.3.2.2. Cell Therapy Packaging Product Portfolio
6.3.2.3. Recent Developments and Future Outlook

6.3.3. Thermo Fisher Scientific
6.3.3.1. Company Overview
6.3.3.2. Cell Therapy Packaging Product Portfolio
6.3.3.3. Recent Developments and Future Outlook

6.3.4. West Pharmaceutical Services
6.3.4.1. Company Overview
6.3.4.2. Cell Therapy Packaging Product Portfolio
6.3.4.3. Recent Developments and Future Outlook

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Methodology and Key Input Parameters
7.3. Cell Therapy Packaging Service Providers
7.3.1. Companies based in North America
7.3.2. Companies based in Europe and Asia Pacific

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Packaging: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Purpose of Partnership
8.3.5. Analysis by Type of Service(s) Covered
8.3.6. Most Active Players: Analysis by Number of Partnerships
8.3.7. Regional Analysis
8.3.8. Intercontinental and Intracontinental Agreements

9. LIKELY PARTNER ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Potential Strategic Partners for Cell Therapy Packaging Providers in North America
9.3.1. Most Likely Partners
9.3.2. Likely Partners
9.3.3. Less Likely Partners

9.4. Potential Strategic Partners for Cell Therapy Packaging Providers in Europe
9.4.1. Most Likely Partners
9.4.2. Likely Partners
9.4.3. Less Likely Partners

9.5. Potential Strategic Partners for Cell Therapy Packaging Providers in Asia Pacific and Rest of the World
9.5.1. Most Likely Partners
9.5.2. Likely Partners
9.5.3. Less Likely Partners

10. CELL THERAPY DEVELOPERS AND MANUFACTURERS: CASE STUDY
10.1. Chapter Overview
10.2. Cell Therapy Manufacturers: Overall Market Landscape
10.2.1. Analysis by Year of Establishment
10.2.2. Analysis by Company Size
10.2.3. Analysis by Location of Headquarters
10.2.4. Analysis by Location of Manufacturing Facility
10.2.5. Analysis by Type of Cell(s) Manufactured
10.2.6. Analysis by Source of Cells
10.2.7. Analysis by Scale of Operation
10.2.8. Analysis by Manufacturing Capabilities / Services
10.2.9. Concluding Remarks

11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Forecast Methodology
11.3 Global Cell Therapy Packaging Services Market, 2021-2030
11.4 Cell Therapy Packaging Services Market, 2021-2030: Distribution by Type of Cell Therapy
11.4.1. Cell Therapy Packaging Services Market for T-Cell Therapies, 2021-2030
11.4.2. Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030
11.4.3. Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030
11.4.4. Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030
11.4.5. Cell Therapy Packaging Services Market for Other Advanced Therapy Medical Products, 2021-2030

11.5. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Package Engineering Design
11.5.1. Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030
11.5.2. Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030

11.6. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Scale of Operation
11.6.1. Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030
11.6.2. Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030

11.7. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Geographical Regions
11.7.1. Cell Therapy Packaging Services Market in North America, 2021-2030
11.7.2. Cell Therapy Packaging Services Market in Europe, 2021-2030
11.7.3. Cell Therapy Packaging Services Market in Asia Pacific, 2021-2030
11.7.4. Cell Therapy Packaging Services Market in Rest of the World, 2021-2030

12. CONCLUDING REMARKS
12.1. Chapter Overview

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Traditional Aseptic Pharmaceutical Filling
Figure 3.2 Advantages of Pharmaceutical Packaging
Figure 3.3 Types of Pharmaceutical Packaging
Figure 3.4 Packaging Containers for Cell Therapies
Figure 3.5 Challenging aspects of Cell Therapy Packaging
Figure 4.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
Figure 4.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
Figure 4.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
Figure 4.4 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
Figure 4.5 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
Figure 4.6 Cell Therapy Packaging Service Providers: Distribution by Packaging Material
Figure 4.7 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
Figure 4.8 Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
Figure 4.9 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
Figure 4.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
Figure 4.11 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
Figure 4.12 Cell Therapy Packaging Service Providers: Distribution by Type of Additional Service(s) Offered
Figure 4.13 Logo landscape: Key Players Offering Additional Services
Figure 5.1 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
Figure 5.2 Cell Therapy Packaging Products: Distribution by Container Fabrication Material
Figure 5.3 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
Figure 5.4 Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
Figure 5.5 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Storage Temperature Conditions
Figure 5.6 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
Figure 5.7 Cell Therapy Packaging Products: Distribution by Usability of Container
Figure 5.8 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
Figure 5.9 Cell Therapy Packaging Product Providers: Distribution by Company Size
Figure 5.10 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
Figure 5.11 Key Players: Analysis by Number of Cell Therapy Packaging Products
Figure 6.1 Almac: Cell Therapy Service Portfolio
Figure 6.2 Catalent Pharma Solutions: Cell Therapy Service Portfolio
Figure 6.3 Cryoport Systems: Cell Therapy Service Portfolio
Figure 6.4 Yourway: Cell Therapy Service Portfolio
Figure 7.1 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in North America
Figure 7.2 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in Europe and Asia-Pacific
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
Figure 8.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
Figure 8.6 Most Active Players: Distribution by Number of Partnerships
Figure 8.7 Partnerships and Collaborations: Distribution by Location of Parent Company
Figure 8.8 Partnerships and Collaborations: Distribution by Location of Partner Company
Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Cell Therapy Manufacturers: Distribution by Year of Establishment
Figure 10.2 Cell Therapy Manufacturers: Distribution by Company Size
Figure 10.3 Cell Therapy Manufacturers: Distribution by Location of Headquarters
Figure 10.4 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
Figure 10.5 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 10.6 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 10.7 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
Figure 10.8 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
Figure 10.9 Cell Therapy Manufacturers: Distribution by Source of Cells
Figure 10.10 Cell Therapy Manufacturers: Distribution by Scale of Operation
Figure 10.11 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
Figure 11.1 Global Cell Therapy Packaging Services Market, 2021-2030 (USD Million)
Figure 11.2 Cell Therapy Packaging Services Market for T -Cell based Therapies, 2021-2030 (USD Million)
Figure 11.3 Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030 (USD Million)
Figure 11.4 Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030 (USD Million)
Figure 11.5 Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030 (USD Million)
Figure 11.6 Cell Therapy Packaging Services Market for Other Advanced Therapy Medicinal Products, 2021-2030 (USD Million)
Figure 11.7 Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030 (USD Million)
Figure 11.8 Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030 (USD Million)
Figure 11.9 Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030 (USD Million)
Figure 11.10 Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030 (USD Million)
Figure 11.11 Cell Therapy Packaging Services Market in North America, 2021-2030 (USD Million)
Figure 11.12 Cell Therapy Packaging Services Market in Europe, 2021-2030 (USD Million)
Figure 11.13 Cell Therapy Packaging Services Market in Asia- Pacific, 2021-2030 (USD Million)
Figure 11.14 Cell Therapy Packaging Services Market in Rest of the World, 2021-2030 (USD Million)
Figure 12.1 Conclusion

List Of Tables

Table 4.1    Cell Therapy Packaging Service Providers
Table 4.2    Cell Therapy Packaging Service Providers: Information on Package Engineering Design, Type of Packaging, Packaging Material and Type of Passive System Used
Table 4.3    Cell Therapy Packaging Service Providers: Information on Temperature Ranges Supported and Type of Cells Handled
Table 4.4    Cell Therapy Packaging Service Providers: Information on Additional Services Offered
Table 5.1    Cell Therapy Packaging Products: Information on Type of Packaging Container and Container Fabrication Material
Table 5.2    Cell Therapy Packaging Products: Information on Storage Temperature Conditions, Packaging Volume, Type of Cells Stored and Availability of Single-use Product
Table 5.3    Cell Therapy Packaging Product Providers: List of Industry Players
Table 6.1    Cell Therapy Packaging Service and Product Providers: List of Companies Profiled
Table 6.2    Almac: Company Snapshot
Table 6.3    Almac: Recent Developments and Future Outlook
Table 6.4    Cryoport Systems: Company Snapshot
Table 6.5    Cryoport Systems: Recent Developments and Future Outlook
Table 6.6    Catalent Pharma Solutions: Company Snapshot
Table 6.7    Catalent Pharma Solutions: Recent Developments and Future Outlook
Table 6.8    Yourway: Company Snapshot
Table 6.9    Lufthansa Cargo: Company Snapshot
Table 6.10    Lufthansa Cargo: Product Portfolio
Table 6.11    Lufthansa Cargo: Recent Developments and Future Outlook
Table 6.12    Saint-Gobain Life Sciences: Company Snapshot
Table 6.13    Saint-Gobain Life Sciences: Product Portfolio
Table 6.14    Thermo Fisher Scientific: Company Snapshot
Table 6.15    Thermo Fisher Scientific: Product Portfolio
Table 6.16    Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 6.17    West Pharmaceutical Services: Company Snapshot
Table 6.18    West Pharmaceutical Services: Product Portfolio
Table 6.19    West Pharmaceutical Services: Recent Developments and Future Outlook
Table 7.1    Cell Therapy Packaging: List of Partnerships and Collaborations, 2016-2021
Table 7.2    Partnerships and Collaborations: Information on Type of Service(s) Covered
Table 9.1    Most Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
Table 9.2    Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
Table 9.3    Less Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
Table 9.4    Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
Table 9.5    Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
Table 9.6    Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
Table 9.7    Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
Table 9.8    Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
Table 9.9    Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
Table 10.1    Cell Therapy Manufacturers: List of Industry Players
Table 10.2    Cell Therapy Manufacturers: Information on Type of Cells Manufactured
Table 10.3    Cell Therapy Manufacturers: Information on Source of Cells
Table 10.4    Cell Therapy Manufacturers: Information on Scale of Operation
Table 10.5    Cell Therapy Manufacturers: Information on Type of Manufacturing Capabilities / Services
Table 13.1    Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
Table 13.2    Cell Therapy Packaging Service Providers: Distribution by Company Size
Table 13.3    Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
Table 13.4    Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
Table 13.5    Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
Table 13.6    Cell Therapy Packaging Service Providers: Distribution by Packaging Material
Table 13.7    Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
Table 13.8    Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
Table 13.9    Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
Table 13.10    Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
Table 13.11    Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
Table 13.12    Cell Therapy Packaging Service Providers: Distribution by Type of Additional Services Offered
Table 13.13    Cell Therapy Packaging Products: Distribution by Type of Packaging Container
Table 13.14    Cell Therapy Packaging Products: Distribution by Container Fabrication Material
Table 13.15    Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
Table 13.16    Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
Table 13.17    Cell Therapy Packaging Products: Distribution by Type of Container and Storage Temperature Conditions
Table 13.18    Cell Therapy Packaging Products: Distribution by Type of Cells Packed
Table 13.19    Cell Therapy Packaging Products: Distribution by Usability of Container
Table 13.20    Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
Table 13.21    Cell Therapy Packaging Product Providers: Distribution by Company Size
Table 13.22    Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
Table 13.23    Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021 (till April)
Table 13.24    Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.25    Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
Table 13.26    Partnerships and Collaborations: Distribution by Purpose of Partnerships
Table 13.27    Partnerships and Collaborations: Distribution by Type of Service(s) Covered
Table 13.28    Most Active Players: Distribution by Number of Partnerships
Table 13.29    Partnerships and Collaborations: Distribution by Location of Parent Company
Table 13.30    Partnerships and Collaborations: Distribution by Location of Partner Company
Table 13.31    Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Partnerships
Table 13.32    Cell Therapy Manufacturers: Distribution by Year of Establishment
Table 13.33    Cell Therapy Manufacturers: Distribution by Company Size
Table 13.34    Cell Therapy Manufacturers: Distribution by Location of Headquarters
Table 13.35    Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
Table 13.36    Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
Table 13.37    Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
Table 13.38    Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
Table 13.39    Cell Therapy Manufacturers: Distribution by Type of Manufacturers
Table 13.40    Cell Therapy Manufacturers: Distribution by Source of Cells
Table 13.41    Cell Therapy Manufacturers: Distribution by Scale of Operation
Table 13.42    Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
Table 13.43    Global Cell Therapy Packaging Services Market, 2021-2030 (USD Million)
Table 13.44    Cell Therapy Packaging Services Market for T- Cell based Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.45    Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.46    Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.47    Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.48    Cell Therapy Packaging Services Market for Other Advanced Therapy Medicinal Products, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.49    Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.50    Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.51    Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.52    Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.53    Cell Therapy Packaging Services Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.54    Cell Therapy Packaging Services Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.55    Cell Therapy Packaging Services Market in Asia Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.56    Cell Therapy Packaging Services Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)

List Of Companies

  1. 3P Biopharmaceuticals
  2. A2 Biotherapeutics
  3. A4P
  4. AbClon
  5. Abeona Therapeutics
  6. AccuResearch Korea
  7. Achilles Therapeutics
  8. Adaptimmune Therapeutics
  9. Adicet Bio
  10. ADVATIS
  11. Advent Biologics
  12. Aegle Therapeutics
  13. Aeon Therapeutics
  14. AffyImmune Therapeutics
  15. AGC Biologics
  16. AgenTus Therapeutics
  17. Akron Biologics
  18. Alitalia
  19. Allele Biotechnology and Pharmaceuticals
  20. AlLife Medicine
  21. Allogene Therapeutics
  22. Almac
  23. Almog
  24. Altaco XXI
  25. Angiocrine Bioscience
  26. Anterogen
  27. apceth Biopharma (acquired by Hitachi Chemical)
  28. Arbele
  29. Arcellx
  30. Aseptic Technologies
  31. Aspire Health Science
  32. Astellas Pharma
  33. Atara Biotherapeutics
  34. Athersys
  35. Atlantis Bioscience
  36. Aurora Biopharma
  37. Asutrianova
  38. Autolus Therapeutics
  39. Axis Biotec
  40. Azidus
  41. Baylx
  42. Beijing Biohealthcare Biotechnology
  43. Beijing Doing Biomedical
  44. Beijing Sanwater Biological Technology
  45. Bellicum Pharmaceuticals
  46. BHI Therapeutic Sciences
  47. Bio Elpida
  48. Biocair
  49. BioCardia
  50. Bioceltech Therapeutics
  51. BioCentriq
  52. BioInno Bioscience
  53. Bioinova
  54. BioNTech Manufacturing
  55. Bioquark
  56. BioRestorative Therapies
  57. Biotech & Pharma Logistics
  58. Biowy
  59. bluebird bio
  60. BlueRock Therapeutics (acquired by Bayer)
  61. Bone Therapeutics
  62. BrainStorm Cell Therapeutics
  63. Bristol Myers Squibb
  64. Brooks Life Sciences
  65. Bukwang Pharmaceutical
  66. Caladrius Biosciences
  67. Capricor Therapeutics
  68. Carina Biotech
  69. CARsgen Therapeutics
  70. CAR-T (Shanghai) Biotechnology 
  71. Cartesian Therapeutics
  72. Cartherics
  73. Catalent Biologics
  74. Celgene
  75. Celixir
  76. Cell and Gene Therapy Catapult
  77. Cell Medica
  78. Cell Therapies
  79. CellBios
  80. Cell-Easy
  81. Cellectis
  82. Cellerant Therapeutics
  83. Cellex
  84. Cellin Technologies
  85. CellMP
  86. CellProtect Nordic Pharmaceuticals
  87. CellProthera
  88. Cellular Biomedicine
  89. Celonic 
  90. Celularity
  91. Celyad Oncology
  92. CENTOGENE
  93. Cesca Therapeutics
  94. CHA Biotech
  95. Chiesi
  96. China Immunotech (Beijing) Biotechnology
  97. China Regenerative Medicine
  98. Chongqing Precision Biotech
  99. Clean Cells
  100. Co.don
  101. Cognate BioServices (acquired by Charles River Laboratories)
  102. CoImmune
  103. ColdStash
  104. Cook MyoSite
  105. Cook Pharmica
  106. CORESTEM    
  107. Creative Biolabs
  108. CRISPR Therapeutics
  109. Critical Transport Solutions Australia
  110. Cryo-Cell
  111. CryoGene
  112. CRYOPDP (acquired by Cryoport)
  113. Cryoport
  114. CSafe Global
  115. Cynata Therapeutics
  116. Cytiva
  117. CytoMed Therapeutics
  118. Cytopeutics
  119. Cytovac
  120. Dendreon Pharmaceuticals
  121. DiscGenics
  122. DWK Life Sciences
  123. EHL Bio
  124. ElevateBio
  125. Eli Lilly
  126. EpiBone
  127. Eutilex
  128. Ever Supreme Bio Technology
  129. EVERSANA
  130. EUMA Biotech
  131. Fate Therapeutics
  132. Ferrer Internacional
  133. Fibrocell Science
  134. Formula Pharmaceuticals
  135. Fortress Biotech
  136. Fosun Kite Biotechnology
  137. Froceth
  138. FUJIFILM Irvine Scientific
  139. Gamida Cell
  140. GC Cell
  141. GE Healthcare
  142. GenCure
  143. Genenta Science
  144. GenIbet Biopharmaceuticals
  145. Genus Oncology
  146. GigaGen
  147. GlaxoSmithKline
  148. Global Cell Med
  149. Glycostem Therapeutics
  150. Gracell Biotechnologies
  151. GC Pharma
  152. Greiner Bio-One
  153. Gwo xi Stem Cell
  154. Hebei Newtherapy BIo-Pharma technology
  155. Hebei Senlang Biotechnology
  156. Helix BioPharma
  157. HemaCare
  158. Hemostemix
  159. Histocell
  160. Hitachi Chemical
  161. Holostem Terapie Avanzate
  162. Hope Biosciences
  163. Horizon Discovery
  164. Hrain Biotechnology
  165. iCell Gene Therapeutics
  166. Icell Kealex Therapeutics
  167. ICS
  168. ilaya
  169. Immatics
  170. Immetacyte
  171. Immune Therapeutics
  172. Immuneel Therapeutics
  173. Immunocore
  174. Immunovative Therapies
  175. IncoCell Tianjin
  176. INNOFORCE
  177. Innovative Cellular Therapeutics
  178. Instant Systems
  179. Instil Bio
  180. Intellia Therapeutics
  181. International Stem Cell
  182. Invectys
  183. Iovance Biotherapeutics
  184. Ixaka
  185. Janssen
  186. Japan Regenerative Medicine
  187. Japan Tissue Engineering
  188. jCyte
  189. Jiuzhitang Maker Cell Technology
  190. Juno Therapeutics
  191. Juventas Cell Therapy
  192. JW Therapeutics
  193. JW CreaGene
  194. Kadimastem
  195. KAEDI
  196. Kangstem Biotech
  197. KBI Biopharma
  198. Kiadis Pharma
  199. Kite Pharma 
  200. KLSMC Stem Cells
  201. KSQ Therapeutics
  202. K-Stem Cell
  203. Kymanox
  204. Lai
  205. LATAM Cargo
  206. Legend Biotech
  207. Leucid Bio
  208. LifeCell
  209. Lineage Cell Therapeutics
  210. Lion TCR
  211. Living Pharma
  212. Longeveron
  213. Lonza
  214. Lufthansa Cargo
  215. Lykan Bioscience
  216. Macopharma
  217. Magellan Biologicals
  218. Magenta Therapeutics
  219. Marken
  220. Marker Therapeutics
  221. McKesson
  222. Med Cell Bahamas
  223. Medeor Therapeutics
  224. Medigene 
  225. MEDINET
  226. MEDIPOST
  227. Medisix Therapeutics 
  228. Melbourne Stem Cell Centre
  229. Meridigen Biotech
  230. Mesoblast
  231. Miltenyi Biomedicine
  232. Minaris Regenerative Medicine
  233. Minerva Biotechnologies
  234. MingJu Therapeutics
  235. Minovia Therapeutics
  236. MNX Global Logistics
  237. MolMed
  238. Müller + Müller (acquired by DWK Life Sciences)
  239. Multimmune
  240. Mustang Bio
  241. MVE Biological Solutions
  242. Nanjing Bioheng Biotech
  243. NanoCool
  244. NantKwest
  245. Nature Cell
  246. NeuroGeneration
  247. NextCell Pharma
  248. Nikon CeLL Innovation
  249. Nipro Europe Group Companies
  250. Nkarta
  251. NKMax America
  252. Nohla Therapeutics
  253. Noile-Immune Biotech
  254. Noray Biosciences Group
  255. Novadip Biosciences 
  256. Novartis
  257. Novex Innovations
  258. NuVasive
  259. Obsidian Therapeutics
  260. Ology Bioservices
  261. Orca Bio
  262. Orchard Therapeutics
  263. OrganaBio
  264. OriGen Biomedical
  265. Orthofix
  266. Osiris Therapeutics
  267. Oxford Biomedica
  268. PackGene Biotech
  269. PACT Pharma
  270. Parexel
  271. Patheon
  272. PeproMene Bio
  273. Personalized Stem Cells
  274. PersonGen BioTherapeutics
  275. PharmaBio
  276. Pharmicell
  277. Phio Pharmaceuticals
  278. Pluristem Therapeutics
  279. Plus Therapeutics
  280. Poseida Therapeutics
  281. Precigen
  282. Precision BioSciences
  283. Promethera Biosciences
  284. Protheragen
  285. Provia Laboratories
  286. Q Therapeutics
  287. Quick
  288. R3 Stem Cell
  289. Regeneus
  290. Regenexx
  291. Reliance Life Sciences
  292. ReNeuron
  293. Riordan Technologies
  294. Riyadh Pharma
  295. ROHTO Pharmaceutical
  296. Roslin Cell Therapies
  297. Roylance Pharma
  298. RTI Surgical
  299. Rubius Therapeutics
  300. S.Biomedics
  301. SABZ Biomedicals
  302. Saint-Gobain
  303. Salvat
  304. SanBio
  305. Sangamo Therapeutics
  306. SAVSU Technologies (acquired by BioLife Solutions)
  307. SCHOTT
  308. Sclnow Biotechnology 
  309. SCM Lifescience
  310. Seattle Genetics
  311. Seneca Biopharma
  312. Sensei Biotherapeutics
  313. Sentien Biotechnologies
  314. Sequel Logistics
  315. Servier
  316. Sexton Biotechnologies
  317. SGD Pharma
  318. Shandong Qilu Stem Cells Engineering
  319. Shanghai Biomed-Union Biotechnology
  320. Shanghai GeneChem
  321. Shanghai iCELL Biotechnology
  322. Shanghai Longyao Biotechnology
  323. Shenzhen Binde Biotechnology
  324. Shenzhen Hornetcorn Biotechnology
  325. Sinobioway Cell Therapy
  326. SiO2 Materials Science
  327. SMT Bio
  328. Sorrento Therapeutics
  329. SOTIO
  330. S-RACMO
  331. Stem Cell Medicine
  332. Stem Med
  333. STEMCELL Technologies
  334. Stemedica Cell Technologies
  335. Steminent Biotherapeutics
  336. Stemmatters
  337. Stempeutics Research
  338. Stryker
  339. Sumitomo Dainippon Pharma
  340. Suzuken
  341. Swiss Medica XXI Century
  342. Swiss WorldCargo
  343. Tactiva Therapeutics
  344. Taiwan Bio Therapeutics
  345. Takara Bio
  346. Takeda Pharmaceutical
  347. Talaris Therapeutics
  348. Targazyme
  349. TC BioPharm
  350. TCR2 Therapeutics
  351. Technoflex
  352. Teneobio
  353. Terumo
  354. Tessa Therapeutics
  355. The Emmes Company
  356. Thermo Fisher Scientific
  357. Tianhe Stem Cell Biotechnologies
  358. Tianjin Ever Union Biotechnology 
  359. Tianjin Mycure Medical Technology
  360. Tianjin Weikai Biological Engineering
  361. TICEBA
  362. TiGenix
  363. TILT Biotherapeutics
  364. time:matters
  365. Timmune Biotech
  366. Tissue Solutions
  367. Tmunity Therapeutics
  368. TPP Techno Plastic Products
  369. TrakCel
  370. TreeFrog Therapeutics
  371. Tscan Therapeutics
  372. TVAX Biomedical
  373. U.S. Stem Cell
  374. Ucardi Biomedical Technology
  375. United Cargo
  376. United Parcel Services (UPS)
  377. United Therapeutics
  378. University College of London
  379. Unum Therapeutics
  380. UWELL Biopharma
  381. va-Q-tec
  382. VcanBio Center for Translational Biotechnology
  383. Vericel
  384. VetStem Biopharma
  385. ViaCyte
  386. Vineti
  387. Viscofan BioEngineering
  388. Vitalant
  389. Waisman Biomanufacturing
  390. Wellington Zhaotai Therapies
  391. West
  392. West Biotherapy
  393. World Courier
  394. Wugen
  395. WuXi Advanced Therapies
  396. Xiangxue Life Sciences
  397. Yourway
  398. Zelluna Immunotherapy
  399. Zumutor Biologics

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com